The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task Force.

Autor: Pottegård A; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark., Klungel O; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands., Winterstein A; Pharmaceutical Outcomes and Policy and Center for Drug Evaluation and Safety, University of Florida, Gainesville, Florida., Huybrechts K; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Hallas J; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark., Schneeweiss S; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Evans S; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK., Bate A; Epidemiology, Pfizer, Tadworth, UK.; Epidemiology, New York University, New York City, New York., Pont L; Pharmacy Department, Faculty of Health, University of Technology Sydney, Sydney, New South Wales, Australia., Trifirò G; Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy., Smith M; Global Patient Safety, Amgen Inc., Thousand Oaks, California.; School of Pharmacy, University of Southern California, Los Angeles, California., Bourke A; Real World Solutions, IQVIA, London, UK.
Jazyk: angličtina
Zdroj: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2019 Dec; Vol. 28 (12), pp. 1640-1641. Date of Electronic Publication: 2019 Oct 22.
DOI: 10.1002/pds.4911
Databáze: MEDLINE